Lengthening and shortening of plasma DNA in hepatocellular carcinoma patientsPeiyong Jiang, Yuk Ming Dennis Lo, John Wong et al.|Proceedings of the National Academy of Sciences|2015Cited by 755
Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the Cancer of the Liver Italian Program staging systemThomas W. T. Leung, Philip J. Johnson, Amanda M. Y. Tang et al.|Cancer|2002Cited by 584
HBx mutants differentially affect the activation of hypoxia-inducible factor-1α in hepatocellular carcinomaLiu Lp, Paul B.S. Lai|British Journal of Cancer|2013Cited by 54
Cytochrome P450 1A2 Metabolizes 17β-Estradiol to Suppress Hepatocellular CarcinomaJianwai Ren, Paul B.S. Lai|PLoS ONE|2016Cited by 49
ID1-induced p16/IL6 axis activation contributes to the resistant of hepatocellular carcinoma cells to sorafenibLeilei Niu, Paul B.S. Lai|Cell Death and Disease|2018Cited by 26